Vitality Watch

Dossier pubmed preclinical 26-sep-2026
Animal model, organoid, or cell-culture result — not yet human

The Eukaryotic Host-Microbe-Phage-Nutrition Interplay Determines the Bacterial Effectors of Supplemental Lysine’s Health Benefits: An Experimental Cellular Senescence Model of Digestive Conditions in Older Adults.

Key claim: In an experimental cellular senescence model of older-adult digestive conditions, whether supplemental lysine is beneficial or detrimental depends on host–microbe–phage interactions, cross-feeding, and the presence of pathogenic versus beneficial gut bacteria.

Abstract

Recently, the consumption of various forms of the nutritive amino acid lysine (e.g., nutraceuticals and dietary supplements) has increased, particularly among the elderly, as it cannot be synthesized by the human body and plays a crucial role in several cellular physiological processes, including intestinal calcium and iron absorption, proteinogenesis, and fatty acid metabolism. However, the biochemical and immunological events that occur within the eukaryotic host-microbe-phage-nutrition interaction, especially when high amounts of lysine are consumed in nutraceutical or dietary supplement form by the elderly due to age-related requirements, as well as the impact on gut bacteria-derived metabolites, have not yet been fully studied. We hypothesized that (1) within an infectious-inflamed digestive milieu, the metabolism of excess extracellular lysine differs between young and senescent digestive cells, and (2) phages within the milieu exhibit alterations in host-microbe cometabolite signal profiles. To address this, we examined how gut microbes and phages, key regulators of eukaryotic host physiology, influence the immunometabolism of excess lysine. By combining two models of young and senescent digestive cells, the pathogenic P. aeruginosa PAO1, the Pseudomonas phage KPP22, and the anti-inflammatory bacterium Intestinimonas butyriciproducens, and simulating the pathogenesis of the interactive process of excessive lysine ingestion, we developed a five-way screening approach to explore key cell readouts, including viability, integrity, and function of the epithelial barrier, as well as cellular immunometabolic responses to exogenous lysine supplementation in cultures under infectious inflammation. Our findings are consistent with the possibility that host-microbe-microbe interactions involving lysine utilization and cross-feeding may influence the effects of lysine supplementation. These effects, whether beneficial or detrimental, can depend on the bacterial community, including the presence of pathogenic or potentially beneficial bacteria, interactions with intestinal phages, and the physiological conditions and metabolic requirements of the host and individual microbial taxa.

Why this matters

Most supplement narratives treat amino acids as context-free inputs, but this preclinical model argues that lysine’s effect on aging gut biology is contingent on which bacteria and phages are present and whether the host epithelium is senescent — the same dose can be helpful or harmful depending on the ecosystem. It’s a mechanistic reminder that supplement effects in older adults with digestive dysfunction may be gated by microbiome state, and it does so in a five-way cellular model that has not been translated to humans.

Source

Link

Briefing card

The Eukaryotic Host-Microbe-Phage-Nutrition Interplay Determines the Bacterial Effectors of Supplemental Lysine's Health Benefits: An Experimental Cellular Senescence Model of Digestive Conditions in Older Adults.
Stage: preclinical · pubmed · 26-sep-2026

If you take supplemental lysine as an older adult, this preclinical model suggests its effect on your gut may depend on which bacteria and phages you already carry, not on the dose alone.

In an experimental cellular senescence model of older-adult digestive conditions, whether supplemental lysine is beneficial or detrimental depends on host–microbe–phage interactions, cross-feeding, and the presence of pathogenic versus beneficial gut bacteria.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.mad.2026.112260

build build 880 · 2bcef25 · 2026-11-18